Recombinant Human Claudin-18/CLDN18.2 Protein-Nanodisc Protein (Baculovirus)，His & Flag

Claudin-6 (CLDN6) is a member of the claudin family of proteins, which are integral components of tight junctions in epithelial tissues, playing crucial roles in maintaining cell-cell adhesion and regulating paracellular permeability. Dysregulation of CLDN6 expression has been associated with various cancers, making it an important target for therapeutic interventions. However, studying CLDN6 has been challenging due to its complex interactions within cellular membranes and its difficulty in purification and characterization. The use of nanodiscs—small, membrane-mimicking systems composed of phospholipids and scaffold proteins—provides a versatile platform for the reconstitution of membrane proteins in a stable, soluble form. Recent advancements in the design of CLDN6 protein-nanodisc complexes allow researchers to circumvent traditional obstacles in membrane protein research, facilitating detailed structural and functional studies. By employing recombinant DNA techniques to produce CLDN6 and integrate it into nanodiscs, researchers aim to elucidate the protein's biophysical properties, interactions with other membrane proteins, and its role in cellular contexts. Additionally, this approach holds promise for therapeutic applications, including the development of targeted drug delivery systems or vaccines that exploit the unique antigenic properties of CLDN6 in cancer immunotherapy. Overall, the combination of CLDN6 and nanodisc technology represents a cutting-edge strategy in membrane protein research, furthering our understanding of tight junction dynamics and their implications in health and disease.